Preadmission statin use improves the outcome of less severe sepsis patients - a population-based propensity score matched cohort study

In this national cohort study, preadmission statin therapy before sepsis development was associated with a 12% reduction in mortality when compared with patients who never received a statin. There were no consistent beneficial effects of statins in all patient subgroups.